PROPAG-AGEING focused on Parkinson's Disease propagation mechanisms; MAIA develops brain-derived prosthetic control for brain-injured patients.
AZIENDA UNITA' SANITARIA LOCALE DI BOLOGNA
Bologna clinical research institute contributing neuroscience expertise, patient cohorts, and healthcare system data to European health and AI projects.
Their core work
Bologna's local health authority operates under the IRCCS Istituto delle Scienze Neurologiche, a nationally recognized clinical research institute specializing in neurological and neurodegenerative diseases. In H2020, they contribute clinical cohorts, patient data, and medical expertise to European research consortia studying ageing, mental health, and integrated care. Their work bridges clinical practice with population-level health research, bringing real-world patient access and healthcare delivery experience that purely academic partners cannot offer.
What they specialise in
H-WORK addresses mental health interventions in workplaces; ESCAPE targets patient-centred depression treatment through biopsychosocial care pathways.
ORCHESTRA connected European cohorts for SARS-CoV-2 response using federated learning and population-based studies.
ENLIGHTENme investigates the health effects of artificial light exposure, light pollution, and circadian disruption in urban settings.
MAIA develops adaptive AI systems for brain-computer interfaces and prosthetic device control for patient autonomy.
How they've shifted over time
Their early H2020 work (2015-2020) centred on neurodegenerative disease mechanisms and occupational mental health, with PROPAG-AGEING on Parkinson's and H-WORK on workplace well-being. From 2021 onward, they diversified significantly into AI-assisted neurorehabilitation (MAIA), environmental determinants of health like light pollution (ENLIGHTENme), and integrated biopsychosocial care models (ESCAPE). The shift shows a move from studying diseases in isolation toward understanding health in broader environmental, technological, and systems-level contexts.
Moving toward interdisciplinary health research that combines clinical neuroscience with AI, environmental factors, and patient-centred care models — expect future interest in digital health and urban health determinants.
How they like to work
Primarily a consortium participant (4 of 6 projects), with one coordination role (PROPAG-AGEING) and one third-party contribution (ORCHESTRA). With 86 unique partners across 24 countries, they are well-networked across Europe but typically contribute clinical expertise and patient cohorts rather than leading project design. This makes them a reliable, low-friction partner who brings real clinical infrastructure to research consortia.
Broad European network spanning 86 unique partners across 24 countries, indicating extensive reach well beyond Italy. Their diverse project topics mean their network spans neuroscience, public health, AI, and environmental health communities.
What sets them apart
As a public health authority with IRCCS (nationally recognized research hospital) status, they offer something rare: direct access to clinical populations and healthcare delivery systems combined with research-grade capabilities. Most academic partners can do research but lack operational healthcare infrastructure; most hospitals lack research culture. Bologna's health authority bridges both, making them especially valuable for projects that need real-world clinical validation or population-level health data from an active care system.
Highlights from their portfolio
- PROPAG-AGEINGTheir only coordinated project and largest funding (EUR 745K), studying Parkinson's disease propagation — demonstrates they can lead European-scale research.
- MAIAMarks a strategic pivot into AI-driven brain-computer interfaces and neurorehabilitation, connecting their neuroscience roots with emerging technology.
- ENLIGHTENmeTheir second-largest funding (EUR 338K) and an unusual topic for a health authority — investigating how urban lighting affects circadian rhythms and public health.